Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roos

Showing results (231-240 of 608) with videos related to

Pageof 61
Sort By:
Urology|December 15, 2010
Oncologic long-term outcome of elective nephron-sparing surgery versus radical nephrectomy in patients with renal cell carcinoma stage pT1b or greater in a matched-pair cohortFrederik C Roos, Walburgis Brenner, Melanie Müller, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 7, 2002
[Comparable case finding percentages of osteoporosis despite diverging reasons for ordering bone densitometry by general practitioners and specialists]E van der Poest Clement, J van Hartskamp, J C Roos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1997
The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient menN Bravenboer, P Holzmann, H de Boer, et al.
Journal of Huntington'S Disease|July 27, 2014
Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten yearsEllen P Hart, Eve M Dumas, Erik J Giltay, et al.
General Hospital Psychiatry|February 23, 2008
Behavioural problems in Huntington's disease using the Problem Behaviours AssessmentElisabeth M Kingma, Erik van Duijn, Reinier Timman, et al.
Therapeutic Advances in Rare Disease|November 13, 2023
Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogeneticsStephanie Feleus, Maaike van der Lee, Jesse J Swen, et al.
Brain Pathology (Zurich, Switzerland)|January 20, 2012
Paraventricular nucleus neuropeptide expression in Huntington's disease patientsDaniel J van Wamelen, N Ahmad Aziz, Jasper J Anink, et al.
Oral Diseases|November 25, 2003
Radioimmunodiagnosis of lymph node metastases in head and neck cancerR de Bree, J C Roos, I Verel, et al.
Bone|April 6, 2002
Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal womenS J M Neele, R Evertz, G De Valk-De Roo, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 1991
[The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma]M R Buist, J C Roos, J B Vermorken, et al.
Pageof 61

Showing results (231-240 of 608) with videos related to

Sort By:
Pageof 61
Urology|December 15, 2010
Oncologic long-term outcome of elective nephron-sparing surgery versus radical nephrectomy in patients with renal cell carcinoma stage pT1b or greater in a matched-pair cohortFrederik C Roos, Walburgis Brenner, Melanie Müller, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 7, 2002
[Comparable case finding percentages of osteoporosis despite diverging reasons for ordering bone densitometry by general practitioners and specialists]E van der Poest Clement, J van Hartskamp, J C Roos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1997
The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient menN Bravenboer, P Holzmann, H de Boer, et al.
Journal of Huntington'S Disease|July 27, 2014
Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten yearsEllen P Hart, Eve M Dumas, Erik J Giltay, et al.
General Hospital Psychiatry|February 23, 2008
Behavioural problems in Huntington's disease using the Problem Behaviours AssessmentElisabeth M Kingma, Erik van Duijn, Reinier Timman, et al.
Therapeutic Advances in Rare Disease|November 13, 2023
Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogeneticsStephanie Feleus, Maaike van der Lee, Jesse J Swen, et al.
Brain Pathology (Zurich, Switzerland)|January 20, 2012
Paraventricular nucleus neuropeptide expression in Huntington's disease patientsDaniel J van Wamelen, N Ahmad Aziz, Jasper J Anink, et al.
Oral Diseases|November 25, 2003
Radioimmunodiagnosis of lymph node metastases in head and neck cancerR de Bree, J C Roos, I Verel, et al.
Bone|April 6, 2002
Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal womenS J M Neele, R Evertz, G De Valk-De Roo, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 1991
[The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma]M R Buist, J C Roos, J B Vermorken, et al.
Pageof 61